InvestorsHub Logo
Followers 54
Posts 4775
Boards Moderated 0
Alias Born 12/08/2011

Re: None

Thursday, 04/05/2012 11:46:36 AM

Thursday, April 05, 2012 11:46:36 AM

Post# of 129054
Why the FDA will say YES to CBIS...

Some bashers here have said CBIS will fail FDA approval because their product is illegal, but not so!

Check out this DEA memo..

http://www.gpo.gov/fdsys/pkg/FR-2010-11-01/pdf/2010-27502.pdf

SUMMARY: This proposed rule is issued
by the Deputy Administrator of the Drug
Enforcement Administration (DEA) to
modify the listing of the Marinol®
formulation in schedule III so that
certain generic drug products are also
included in that listing.
Several products are currently the
subject of Abbreviated New Drug
Applications (ANDAs) under review by
the U.S. Food and Drug Administration
(FDA). Each product is a generic
formulation of Marinol® and contains
dronabinol, the (-) isomer of delta-9-
(trans)-tetrahydrocannabinol (THC),
which is a schedule I controlled
substance. Due to variations in
formulation, these generic Marinol®
products do not meet the specific
conditions specified in the current
schedule III listing.
This proposed action expands the
schedule III listing to include
formulations having naturally-derived
dronabinol and products encapsulated
in hard gelatin capsules. This would
have the effect of transferring the FDAapproved
versions of such generic
Marinol® products from schedule I to
schedule III.


Pharmas asked the DEA to reschedule because de-novo synthesis of cannabinoids is much costlier than them growing it. Now plant extracted cannabinoid medicines are legal.

I work in the cancer industry as a researcher. It is all bullshit, all about expanding the scientific-medical-industrial complex and not about helping people.

What scares big pharma and the government the most?

Healthy, Educated, Wealthy people who can grow their own food and medicine and not be dependent on the corporate granny state.

CBIS FOREVER!
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.